- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01250964
Endothelial Cell Loss and Induced Astigmatism After Wound-directed and Wound-assisted IOL Injection
Endothelial Cell Loss and Surgically Induced Astigmatism After 2.2 mm Wound Assisted vs 2.4 mm Wound-Directed Clear Corneal Incisions for Intraocular Lens Insertion During Cataract Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cataract surgery (removal of a cloudy lens) is currently performed through increasingly smaller incisions. Bimanual surgery, where two instruments are used to remove the lens, is performed through two 1.4 mm incisions. Typically, one of these incisions is enlarged to 2.2 or 2.4 mm in order that the IOL (artificial lens) can be inserted into the eye. Surgeons insert these lenses by placing a lens injector cartridge completely into the eye (wound-directed insertion) or by placing only the tip inside the incision (wound-assisted insertion). While wound-assisted insertion can be performed through slightly smaller incisions (2.2 mm versus 2.4 mm for wound-directed insertion), both methods of insertion cause some incision enlargement. There is some evidence that wound-assisted insertion can cause very short-term pressure within the eye to go up. Neither method is considered inferior or superior to the other, and the primary investigator (Dr. Kenneth Cohen) routinely uses both methods.
No studies have directly compared wound-healing characteristics between these two methods. We seek to compare differences in:
- Surgically-induced astigmatism (changes in the corneal curvature from cataract surgery incisions.
- Endothelial cell density loss. Endothelial cells line the inside surface of the cornea, and their overall density can be decreased by cataract surgery.
- Best-corrected vision after surgery
- Sizes of the incisions after lens injection
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- Kittner Eye Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Eligible patients include those who undergo uncomplicated cataract extraction surgery and IOL implantation by KLC.
Exclusion Criteria: Patients who:
- suffer from diabetes and have more than mild background diabetic retinopathy,
- have a history of intraocular surgery,
- have a history of ocular trauma,
- have known pathology of the cornea,
- have a history of intraocular inflammation,
- are unable to understand English,
- are decisionally impaired,
- are currently incarcerated, or
- are less than 18 years of age.
No exclusions will be made on the basis of gender, ethnicity, or race.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Wound-assisted lens injection
Wound-assisted lens injection is considered neither superior or inferior to wound-directed lens injection.
|
After cataract removal during cataract surgery, a lens needs to be injected into the eye.
Both arms are routinely used but different methods for injecting the lens.
|
Active Comparator: Wound-directed lens injection
Wound-directed lens injection is neither considered superior nor inferior to wound-assisted lens injection.
|
After cataract removal during cataract surgery, a lens needs to be injected into the eye.
Both arms are routinely used but different methods for injecting the lens.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Surgically induced astigmatism
Time Frame: 1 month
|
measured by topography at 1 month post operative visit
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Endothelial cell loss
Time Frame: one month
|
As measured by specular microscopy
|
one month
|
Best corrected visual acuity
Time Frame: one month
|
By manifest refraction
|
one month
|
Final incision size
Time Frame: intraoperatively (day #0)
|
measured with incision gauges before and after lens injection.
|
intraoperatively (day #0)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Kenneth Cohen, MD, UNC dept. of ophthalmology
Publications and helpful links
General Publications
- Tsuneoka H, Hayama A, Takahama M. Ultrasmall-incision bimanual phacoemulsification and AcrySof SA30AL implantation through a 2.2 mm incision. J Cataract Refract Surg. 2003 Jun;29(6):1070-6. doi: 10.1016/s0886-3350(03)00076-2.
- Kamae KK, Werner L, Chang W, Johnson JT, Mamalis N. Intraocular pressure changes during injection of microincision and conventional intraocular lenses through incisions smaller than 3.0 mm. J Cataract Refract Surg. 2009 Aug;35(8):1430-6. doi: 10.1016/j.jcrs.2009.03.038.
- Osher RH. Microcoaxial phacoemulsification Part 2: clinical study. J Cataract Refract Surg. 2007 Mar;33(3):408-12. doi: 10.1016/j.jcrs.2006.10.055.
- Kohnen T, Klaproth OK. Incision sizes before and after implantation of SN60WF intraocular lenses using the Monarch injector system with C and D cartridges. J Cataract Refract Surg. 2008 Oct;34(10):1748-53. doi: 10.1016/j.jcrs.2008.06.031.
- Ventura AC, Walti R, Bohnke M. Corneal thickness and endothelial density before and after cataract surgery. Br J Ophthalmol. 2001 Jan;85(1):18-20. doi: 10.1136/bjo.85.1.18.
- Masket S, Wang L, Belani S. Induced astigmatism with 2.2- and 3.0-mm coaxial phacoemulsification incisions. J Refract Surg. 2009 Jan;25(1):21-4. doi: 10.3928/1081597X-20090101-04.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10-0435
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataracts
-
Johnson & Johnson Surgical Vision, Inc.Recruiting
-
Johnson & Johnson Surgical Vision, Inc.CompletedCataractsUnited States
-
Wenzhou Medical UniversityCompleted
-
Medical University of ViennaCompleted
-
Hermann Eye CenterCompleted
-
Mark Packer, MD, FACSCompletedCataractsUnited States
-
Medical University of ViennaCompleted
Clinical Trials on Lens insertion during cataract surgery
-
Wenzhou Medical UniversityCompleted
-
University of OxfordOxford University Hospitals NHS TrustTerminated
-
Guy's and St Thomas' NHS Foundation TrustCity, University of LondonNot yet recruitingCataract | Presbyopia | PseudophakiaUnited Kingdom
-
Iladevi Cataract and IOL Research CenterCompletedPostoperative Complications | Posterior Capsule Opacification
-
Sun Yat-sen UniversityRecruitingCongenital CataractChina
-
Sun Yat-sen UniversityRecruitingCongenital CataractChina
-
Universitair Ziekenhuis BrusselNot yet recruiting
-
Cristalens IndustrieRecruiting
-
Federal University of Minas GeraisCompletedCataract | Lens Diseases | Signs and Symptoms | PseudophakiaBrazil
-
The University of Hong KongJanssen, LPNot yet recruiting